Impact1 at Stanford Biodesign

Impact1, in partnership with UCSF, has officially been awarded 5 additional years of FDA funding for the UCSF-Stanford Pediatric Device Consortium (PDC)!

We are thrilled to continue our collaborations with UCSF, Stanford Byers Center for Biodesign, the other four PDC programs, industry experts, philanthropists, investors, and more as we collectively work towards the advancement of pediatric health outcomes and equity.

Additional new collaborations are included in this grant cycle, so stay tuned for more updates and opportunities! And let us know - what are you hoping to see from the USCF-Stanford PDC in the next 5 years?

Now accepting applications for our Maternal Health Pitch Competition! Prizes up to $25,000 will be awarded.

Apply here by April 3rd: https://lnkd.in/ge4x-fMq

Impact1 Maternal Health Pitch Competition Thank you for your interest in the Impact1 Maternal Health Pitch Competition. Please review the below eligibility criteria and complete the application. Eligibility Criteria Stage: Less than $2 million in private investment or venture funding Target population: Maternal and fetal health Geography: T...

Impact1 is dedicated to advancing pediatric, fetal, and maternal health technology to impact lives from day one. In 2022, we were thrilled to support 39 teams of innovators who share that mission through coaching, connections, funding, and more.

What exactly is Impact1? Formerly known as the Pediatric Health Technology Program at Stanford Biodesign, we work to educate entrepreneurs, conduct translational research, and engage in health policy reform. Our leadership team includes James Wall, Janene Fuerch, Kunj Sheth, Juliana Perl, Elisabet Rosàs Canyelles, and Yair Blumenfeld.

Learn more here: https://biodesign.stanford.edu/programs/impact1.html

And join us on LinkedIn and Twitter:
https://www.linkedin.com/company/impact1biodesign
https://twitter.com/Impact1Stanford